Intravenous nicorandil cut the risk of periprocedural myocardial injury (pMI) after percutaneous coronary intervention (PCI) by 49 percent among patients 65 and older, according to a substudy of a randomized trial published in PLOS One.

Medtronic’s IN.PACT Admiral drug-coated balloon (DCB) has received an expanded indication from the FDA and is now cleared to treat long superficial femoral artery lesions up to 360 millimeters, the company announced April 23.

Telemedicine is becoming increasingly popular across all fields of medicine, but doctors aren’t necessarily taught how to use it effectively, a researcher and physician wrote in the Washington Post.

About 47 percent of on-duty firefighter deaths are heart-related, according to the U.S. Fire Administration (USFA).

Heart disease patients who are slow walkers are at a higher risk of hospitalization than their speedier counterparts, according to research presented April 20 at EuroPrevent 2018.

An antioxidant that targets cellular mitochondria appeared to reverse age-related vascular changes by 15 to 20 years in older adults, according to a small, first-in-human study published April 16 in Hypertension.

The FDA has approved a firmware update aimed at addressing two previously reported issues with some of Abbott’s implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).

Nearly one in 10 patients who receive percutaneous coronary intervention (PCI) end up back in the hospital with an unplanned readmission within 30 days, according to a study published online April 2 in JACC: Cardiovascular Interventions. These readmissions are usually for noncardiac causes and heavily linked to a patient’s comorbidities and place of discharge, the researchers found.

Cardiologists earn an average of $423,000 annually, according to the 2018 Medscape Cardiologist Compensation Report, up from $410,000 in last year’s survey. That salary puts cardiology third among all specialties—behind only plastic surgery ($501,000) and orthopedics ($497,000).

The FDA’s voluntary sodium reduction goals for packaged and processed foods could greatly reduce or delay deaths from cardiovascular disease (CVD) in the U.S. and are cost-saving even in pessimistic simulations, according to a study published online April 10 in PLOS Medicine.